Related Experiment Video

Updated: Jun 26, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

[Expression of interleukin-17 in hepatitis B related liver fibrosis]

Yan Xu1, Wen-jun DU, Lai-ying Qin

  • 1Intervention Center, Jinan Infectious Disease Hospital, Medical College of Shandong University, Jinan, China.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology
|January 29, 2009
PubMed

Insights

Interleukin-17 (IL-17) levels are elevated in hepatitis B virus (HBV) related liver diseases, particularly in liver cirrhosis. This suggests IL-17 plays a role in the progression of HBV liver fibrosis.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Context:

  • Chronic hepatitis B virus (HBV) infection can lead to severe liver damage.
  • Liver fibrosis is a key pathological process in chronic liver diseases.
  • Interleukin-17 (IL-17) is a pro-inflammatory cytokine with known roles in various diseases.

Purpose:

  • To investigate the association between interleukin-17 (IL-17) levels and the pathogenesis of chronic hepatitis B virus (HBV) related liver diseases.
  • To specifically examine the role of IL-17 in the development and progression of liver fibrosis in HBV infection.

Summary:

  • Serum IL-17 levels and IL-17 mRNA expression in peripheral blood mononuclear cells (PBMCs) were significantly higher in patients with chronic hepatitis B (CHB), liver cirrhosis (LC), primary hepatitis carcinoma (PHC), and chronic severe hepatitis compared to healthy controls.
  • IL-17 levels and liver fibrosis markers (C-IV, LN, HA) were highest in the liver cirrhosis group, showing a positive correlation with Child-Pugh scores.
  • These findings indicate a significant increase in IL-17 associated with the severity of HBV-related liver disease and fibrosis.

Impact:

  • Highlights IL-17 as a potential biomarker for assessing the severity of HBV-related liver disease.
  • Suggests IL-17 as a potential therapeutic target for managing hepatitis B virus-related liver fibrosis.
  • Provides insights into the immunological mechanisms underlying liver fibrosis in chronic hepatitis B.
Abstract

More Related Videos

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...